Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL.
Mol Cancer Ther
; 17(8): 1705-1716, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-29748211
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myeloid-Lymphoid Leukemia Protein
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Type of study:
Guideline
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2018
Document type:
Article
Affiliation country:
Italy